Table 2 Multivariable Cox’s proportional hazard regression model to predict overall survival
Variable | HR (95% CI) | P value |
|---|---|---|
Sex (male vs. female) | 0.81 (0.44–1.50) | 0.510 |
Age (≤ 65 vs. > 65) | 0.68 (0.42–1.10) | 0.113 |
Diversion type (conduit vs. cutaneous ureterostomy) | 1.52 (0.96–2.41) | 0.072 |
Diversion type (neobladder vs. cutaneous ureterostomy) | 0.59 (0.26–1.36) | 0.218 |
Pathological T-stage (MIBC vs. NMIBC) | 3.70 (2.19–6.26) | < 0.001 |
Pathological N-stage (N + vs. N−) | 2.08 (1.08–4.00) | 0.028 |
Smoking history (yes vs. no) | 1.23 (0.78–1.95) | 0.381 |
Neoadjuvant chemotherapy (yes vs. no) | 0.56 (0.20–1.57) | 0.271 |
Pentafecta (yes vs. no) | 0.33 (0.14–0.78) | 0.011 |